longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Pro-Dex

PDEX

72.5504.43% ( +3.075 )
Closed: Sep 18, 16:00:01 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Pro-Dex (NASDAQ:PDEX) Upgraded by Zacks Research to "Strong-Buy" Rating

    Market Beat·2 days ago, 11:30 AM
    PDEX+4.43%
  • Pro-Dex CFO Alisha Charlton disposes of 2,300 common shares worth $140,755

    PUBT·Sep 11 at 12:19 AM
    PDEX+4.43%
  • Biotech Stocks At 52-Week Highs - PDEX +18% On FY'26 Results, ODTX +8%, EOLS, BFRI, DRTS

    rttnews·Sep 8 at 02:33 AM
    BFRI+6.45%PDEX+4.43%
  • Pro-Dex shares are trading higher after the company reported better-than-expected Q4 financial results.

    benzinga_article·Sep 4 at 02:43 PM
    PDEX+4.43%
  • Pro-Dex awards CEO $140,000 cash bonus, CFO $60,000

    PUBT·Aug 28 at 08:00 PM
    PDEX+4.43%
  • Pro-Dex (NASDAQ:PDEX) Stock Passes Above 200-Day Moving Average - Should You Sell?

    Market Beat·Aug 12 at 06:40 AM
    - Pro-Dex share price crossed above its 200-day moving average of $ 53.65, trading as high as $ 67.76 during Tuesday's session. - The company holds a consensus rating of Moderate Buy with a target price of $ 70.00 based on recent analyst updates. - CEO Kirk Richard Lee Van, Jr. sold 4,128 shares of stock valued at $ 257,422.08 on May 22nd.
    PDEX+4.43%BAC-0.77%
  • Pro-Dex (NASDAQ:PDEX) Stock Passes Above 200-Day Moving Average - What's Next?

    Market Beat·Aug 4 at 07:00 AM
    - Pro-Dex share price crossed above its 200-day moving average of $52.60 during trading, reaching as high as $64.34. - The company maintains a market cap of $202.92 million with a price-to-earnings ratio of 17.57 and a debt-to-equity ratio of 0.32. - Several financial institutions adjusted their stakes in the medical instruments supplier, while Wall Street analysts hold a consensus "Hold" rating with a $70.00 price target.
    PDEX+4.43%BAC-0.77%
  • Deconstructing the Value Chain of the Long Tail: From Physical Scarcity to Niche Aggregation

    Global Report·Jul 21 at 09:13 AM
    NXE-1.06%METC-6.01%
  • Pro-Dex director Angelita Domingo disposes of 998 common shares worth $47,145.52

    PUBT·Jul 14 at 10:00 PM
    PDEX+4.43%